防風葛根湯의 안전성에 관한 연구
Study on Safety of Bangpung-galgeun-tang
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
The purpose of this study was to examine to observe single and four weeks repeated toxicity in mice of Bangpung-galgeun-tang (BGT). We investigated to ascertain safety and toxicity of BGT, we divided into single and four weeks repeated administration test. In single test, three groups were administrated different dosages and routes (2 g/㎏/i.p., 4 g/㎏/i.p. and 15 g/㎏/p.o.) of BGT, and in four weeks repeated test, 0.8 g/㎏ BGT was administrated. Control groups were administrated with only saline according to on Korean Food and Drug Administration, respectively. We observed attentively motality, abnormal clinical sign, body weight change, organ weight, AST and ALT of mice after BGT administration. During toxicity experiment period, there was no difference in body weight change, organ weight, AST and ALT among different dose groups. Death were found 3 mice from day 2 to day 3 in single test i.p. group. (2 g/㎏, 4 g/㎏). Several individuals of single test i.p. group were observed that decreased locomotor activity, exophthalmos, bloodshot eyes, loss of eyesight and so on in early period after administration. But there was no difference in clinical signs among p.o. group. These results indicate that BGT have inhibition effects on allergy and suggest that no observable effect level of the test orally administration was considered to be more than 2 g/㎏ in mice under the conditions employed in this study.
Abstract
The purpose of this study was to examine to observe single and four weeks repeated toxicity in mice of Bangpung-galgeun-tang (BGT). We investigated to ascertain safety and toxicity of BGT, we divided into single and four weeks repeated administration test. In single test, three groups were administrated different dosages and routes (2 g/㎏/i.p., 4 g/㎏/i.p. and 15 g/㎏/p.o.) of BGT, and in four weeks repeated test, 0.8 g/㎏ BGT was administrated. Control groups were administrated with only saline according to on Korean Food and Drug Administration, respectively. We observed attentively motality, abnormal clinical sign, body weight change, organ weight, AST and ALT of mice after BGT administration. During toxicity experiment period, there was no difference in body weight change, organ weight, AST and ALT among different dose groups. Death were found 3 mice from day 2 to day 3 in single test i.p. group. (2 g/㎏, 4 g/㎏). Several individuals of single test i.p. group were observed that decreased locomotor activity, exophthalmos, bloodshot eyes, loss of eyesight and so on in early period after administration. But there was no difference in clinical signs among p.o. group. These results indicate that BGT have inhibition effects on allergy and suggest that no observable effect level of the test orally administration was considered to be more than 2 g/㎏ in mice under the conditions employed in this study.
참고문헌 (28)
- 대한 천식 및 알레르기 학회, "천식과 알레르기 질환", pp.431~433 (2002), 군자출판사
- 彭懷仁, "中華醫方精選辭典. 上海", pp.931~ (1998), 上海科學技術文獻出版社
- S. Katayama, "A new method for extraction of extravasated dye in the skin and the influence of fasting stress on passive cutaneous allergy in guinea pigs and rats", Microbiol. Immunol, 22, pp.89~101 (1978)
- Dastych, J., "Murine mast cells exposed to mercuric chloride release granule-associated N-acetyl-beta-d- hexosaminidase and secrete IL-4 and TNF-alpha", J Allergy Clin Immunol, 103, pp.1108~1114 (1999)
- Schwartz, L.B., "Immunologic release of beta-hexosaminidase and beta-glucuronidase from purified rat serosal mast cells", J Immunol, 123, pp.1445~1450 (1979)
- 식품의약품안전청, "의약품등의 독성시험기준, 식품의약품안전청 고시 2005-60호" (1999), 식품의약품안전청
- 국립독성연구원, "표준작업지침서" (2007), 국립독성연구원
- 은희철, "피부면역학", pp.1~2 (1999), 서울대학교출판부
- Halfon, N., "Trends in the hospitalization for acute childhood asthma, 1970-84", Am J Public Health, 76(11), pp.1308~1311 (1986)
- Mitchell, E.A., "Increasing prevalence of asthma in children", N Z Med J, 96(734), pp.463~464 (1983)
- Smith, J.M., "The changing prevalence of asthma in school children", Clin Allergy, 1(1), pp.57~61 (1971)
- 김유영, "설문지와 메타콜린 기관지유발시험을 이용하여 조사한 한국의 소아 천식 유병률", 대한알레르기학회지, 16(2), pp.175~184 (1996)
- 黃兆勝, "中藥學", pp.42~426 (2005), 人民衛生出版社
- Ehrlich, P, "Beitrage zur kenntnis der Anilinfarbunger und ihrer Verwendung in drmikroskopischen Technik", Arch Mikrosk Anast, 13, pp.263~277 (1877)
- Moon, P.D., "Inhibitory effect of Gamibojungikaitang extract on mast cell-mediated allergicreaction in murine Model", J Pharm Pharm Sci, 8(1), pp.94~101 (2005)
- Ennis, M., "Some studies on the release of histamine from mast cells stimulated with polylysine", Br. J. Pharmacol, 70, pp.329~334 (1980)
- 강경진, "상백피가 흰쥐 복강 비만세포의 히스타민 유리와 Calcium uptake에 미치는 영향", 대한면역학회지, 15, pp.91~99 (1993)
- 채옥희, "상백피의 colchicine 유도 비만세포 활성화 억제효과", 대한해부학회지, 32, pp.735~747 (1999)
- B.S. Bochner, "Anaphylaxis", N. Engl. J. Med, 324, pp.1785~1790 (1991)
- Sheffer, A.L., "Anaphylaxis: clinical aspects", Allergy Asthma Proc, 25(1), pp.31~32 (2004)
- Dainaka, J., "Effect of the tridecamer of compound 48", 80, a Ca2+-dependent histamine releaser, on phospholipid metabolism during the early stage of histamine release from rat mast cells, 1986, pp.35(21), 3739~3744
- Lane, S.J., "Mast cell effector mechanisms", J Allergy Clin Immunol, 98(5), pp.S67~S71 (1996)
- Jirapongsananuruk, O., "Clinical applications of cytokines: new directions in the therapy of atopic diseases", Ann Allergy Asthma Immunol, 79(1), pp.5~20 (1997)
- 정해영, "생명과학ㆍ분자의학을 위한 사이토카인 분자생물학", pp.117~124 (2002), 월드사이언스
- 이중달, "그림으로 설명한 병리학", pp.29~ (1991), 고려의학
- 강재성, "세포분자면역학", pp.283~435 (2002), 범문사
- Kim, J.C., "Effects of prenatal exposure to the environmental pollutant 2-bromopropane on embryo-fetal development in rats", Toxicology, 196(1-2), pp.77~86 (2004)
- Kim, J.C., "Subacute toxicity evaluation of a new camptothecin anticancer agent CKD-602 administered by intravenous injection to rats", Regul Toxicol Pharmacol, 40(3), pp.356~369 (2004)